From: Effects of ebselen and N-acetyl cysteine on replicative aging of primary human fibroblast strains
Human CD4+ TCCs | Human CD4+ TCCs | Human peripheral blood & CD4+ T cells ex vivo (derived from 25–30 or 55–60 year old donors) [3] | MRC-5 (Human embryonic lung fibroblasts) | HFF (Human foreskin fibroblasts) |
---|---|---|---|---|
26 & 45Â year old donors [3] | 80Â year old donors [13] | |||
Increase in cumulative PD* | No effect on cumulative PD | Increase in proliferation capacity* | No effect on cumulative PD | |
No effect on induction of SA – β Gal | ||||
Increase in intracellular GSH:GSSG ratio* | No effect on intracellular GSH:GSSG ratio | Increase in intracellular GSH:GSSG ratio* | No effect on induction of cyclin dependent kinase inhibitors (p16, p21) | |
Decrease in levels of oxidative DNA damage* | No effect in levels of oxidative DNA damage | Decrease in levels of oxidative DNA damage* | Intracellular GSH:GSSG ratio remains unchanged | |
No significant changes on the levels of oxidative DNA damage | ||||
No effect on intracellular total glutathione levels | No effect on intracellular total glutathione levels | |||
Increase in intracellular total glutathione levels* | No effect on the increase in phosphorylation of HSP27 with age |